NRx Pharmaceuticals Shares Up on Narrower 3Q Loss
By Natalie WegerNRx Pharmaceuticals shares rose after the company had a narrower loss in the third quarter, beating Wall Street expectations.Shares rose 9.8% to $2.36. The stock is down 13% year to date.The clinical-stage biopharmaceutical company said its third-quarter loss narrowed to $2.2 millio…